Skip to main content

Advertisement

SpringerLink
Log in

[68Ga]Ga-DOTA-FAPI-04 PET/CT depicts metastases from medullary thyroid cancer that [68Ga]Ga-DOTATOC PET/CT missed

  • Image of the Month
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Data availability

The current study data are available from the corresponding author on reasonable request.

References

  1. Kratochwil C, Flechsig P, Lindner T, Abderrahim L, Altmann A, Mier W, et al. (68)Ga-FAPI PET/CT: tracer uptake in 28 different kinds of cancer. J Nucl Med. 2019;60(6):801–5. https://doi.org/10.2967/jnumed.119.227967.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Kuyumcu S, Isik EG, Sanli Y. Liver metastases from medullary thyroid carcinoma detected on (68)Ga-FAPI-04 PET/CT. Endocrine. 2021;74(3):727–8. https://doi.org/10.1007/s12020-021-02800-3.

    Article  CAS  PubMed  Google Scholar 

  3. Kim BH, Kim IJ. Recent updates on the management of medullary thyroid carcinoma. Endocrinol Metab (Seoul). 2016;31(3):392–9. https://doi.org/10.3803/EnM.2016.31.3.392.

    Article  CAS  PubMed  Google Scholar 

  4. Giovanella L, Treglia G, Iakovou I, Mihailovic J, Verburg FA, Luster M. EANM practice guideline for PET/CT imaging in medullary thyroid carcinoma. Eur J Nucl Med Mol Imaging. 2020;47(1):61–77. https://doi.org/10.1007/s00259-019-04458-6.

    Article  PubMed  Google Scholar 

  5. Roman S, Lin R, Sosa JA. Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases. Cancer. 2006;107(9):2134–42. https://doi.org/10.1002/cncr.22244.

    Article  PubMed  Google Scholar 

  6. Kwekkeboom DJ, Reubi J-C, Lamberts S, Bruining H, Mulder A, Oei H, et al. In vivo somatostatin receptor imaging in medullary thyroid carcinoma. J Clin Endocrinol Metab. 1993;76(6):1413–7.

    CAS  PubMed  Google Scholar 

  7. Fortunati E, Argalia G, Zanoni L, Fanti S, Ambrosini V. New PET radiotracers for the imaging of neuroendocrine neoplasms. Curr Treat Options Oncol. 2022;23(5):703–20. https://doi.org/10.1007/s11864-022-00967-z.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Ballal S, Yadav MP, Kramer V, Moon ES, Roesch F, Tripathi M, et al. A theranostic approach of [(68)Ga]Ga-DOTA.SA.FAPi PET/CT-guided [(177)Lu]Lu-DOTA.SA.FAPi radionuclide therapy in an end-stage breast cancer patient: new frontier in targeted radionuclide therapy. Eur J Nucl Med Mol Imaging. 2021;48(3):942–4. https://doi.org/10.1007/s00259-020-04990-w.

    Article  PubMed  Google Scholar 

  9. Pang Y, Zhao L, Meng T, Xu W, Lin Q, Wu H, et al. PET imaging of fibroblast activation protein in various types of cancer using (68)Ga-FAP-2286: comparison with (18)F-FDG and (68)Ga-FAPI-46 in a single-center, prospective study. J Nucl Med. 2023;64(3):386–94. https://doi.org/10.2967/jnumed.122.264544.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, King Hussein Cancer Center (KHCC), Queen Rania Street Al-Jubeiha, Amman, 11941, Jordan

    Akram Al-Ibraheem, Salem Fandi Alyasjeen & Ahmed Saad Abdlkadir

  2. Division of Nuclear Medicine/Department of Radiology and Nuclear Medicine, University of Jordan, Amman, 11942, Jordan

    Akram Al-Ibraheem

  3. Department of Medical Oncology, King Hussein Cancer Center (KHCC), Amman, 11941, Jordan

    Areej Abu Sheikha

Authors
  1. Akram Al-Ibraheem
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Salem Fandi Alyasjeen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ahmed Saad Abdlkadir
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Areej Abu Sheikha
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Akram Al-Ibraheem contributed to the concept and design of this manuscript. Akram Al-Ibraheem, Salem Fandi Alyasjeen, Ahmed Saad Abdlkadir, and Areej Abu Sheikha participated in data acquisition and manuscript revision. Ahmed Saad Abdlkadir drafted the initial manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Akram Al-Ibraheem.

Ethics declarations

Ethics approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Consent to participate

Informed consent was obtained from the patient.

Consent for publication

Not applicable.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Al-Ibraheem, A., Alyasjeen, S.F., Abdlkadir, A.S. et al. [68Ga]Ga-DOTA-FAPI-04 PET/CT depicts metastases from medullary thyroid cancer that [68Ga]Ga-DOTATOC PET/CT missed. Eur J Nucl Med Mol Imaging 50, 4112–4113 (2023). https://doi.org/10.1007/s00259-023-06348-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-023-06348-4

Search

Navigation